Quantinno Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
Quantinno Capital Management's CRVS Position: Q3 2026 in Review
Quantinno Capital Management opened a new position in Corvus Pharmaceuticals (CRVS) in Q3 2026: 16,267 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #3529 among its holdings. This is a return to the name: Quantinno Capital Management previously reported a position in CRVS as recently as Q1 2026.
Quantinno Capital Management first reported a position in CRVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $336K in Q1 2026. 177 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.
- Quantinno Capital Management held 16,267 shares of Corvus Pharmaceuticals worth $187K as of Q3 2026.
- Corvus Pharmaceuticals was a new Quantinno Capital Management position in Q3 2026.
- Corvus Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3529 holding.
- Quantinno Capital Management first reported a position in Corvus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Quantinno Capital Management's Corvus Pharmaceuticals position peaked at $336K in Q1 2026.
- 177 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.